Novel Immunotherapy Selectively Targets Malignant T Cells :

One major hurdle in the development of safe and effective immunotherapies has been the risk of depleting healthy T cells during CAR-T treatment that seeks out a

Related Keywords

Juliam Lewis , Kacier Carlson , Francine Foss , Jingjing Ren , Jungsoo Chang , Xiaofeng Liao , Michael Girardi , Rs Evans Foundation , Nature Communications , Yale Cancer Center , Evans Professor , Yale School , Yale Cancer , Newswise , Mmunotherapy Malignantt Cells Healthy , All Journal News , Cell Biology , Mmunology , Ature Journal , Cancer Center Featured Story 2 , Yale Cancer Center Smilow Hospital ,